Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Neurol.

Sec. Artificial Intelligence in Neurology

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1527020

Quantitative analysis of gait parameters in Parkinson's disease and the clinical significance

Provisionally accepted
Wenchao  YinWenchao Yin1Hong  GaoHong Gao2Beichen  LiangBeichen Liang3Ruichen  LiuRuichen Liu4Yue  LiuYue Liu5Chenxin  ShenChenxin Shen1Xiaohui  NiuXiaohui Niu1Cui  WangCui Wang1*
  • 1Central Hospital of Dalian University of Technology, Dalian, Liaoning Province, China
  • 2Dalian Maritime University, Dalian, Liaoning Province, China
  • 3Georgia Institute of Technology, Atlanta, Georgia, United States
  • 4Dalian University of Technology, Dalian, Liaoning Province, China
  • 5Shenyang Fifth People's Hospital, Shenyang, Liaoning Province, China

The final, formatted version of the article will be published soon.

Background: Gait disorder is one of the clinical manifestations of Parkinson's disease (PD). Investigating the characteristics of gait disorder in patients with PD and the changes in gait before and after taking levodopa is crucial for the recognition, diagnosis and treatment of gait disorders in PD patients.In this study, we measured the gait parameters of 20 patients with PD and 17 healthy controls and analyzed the changes of gait parameters of these patients before and after taking levodopa. We also used gait parameters as input features and MDS-UPDRS III score (which was further subdivided into tremor and non-tremor part score) as output labels to train machine learning regression models.We found that except for cadence and stride time, most gait parameters of PD patients, including plantar dorsiflexion angle, plantar flexion angle, stride length, velocity were all smaller than those of the healthy controls. Moreover, the severity of gait disorders correlated with the severity of motor symptoms. After taking levodopa, the stride length, velocity and cadence were increased, but stride time was decreased. We also found that the trained machine learning model could explain and predict the MDS-UPDRS III score and non-tremor part score, and the non-tremor part score was better than the MDS-UPDRS III score.Our gait assessment work can help clinicians recognize gait disorder in PD patients and predict the severity of clinical symptoms.

Keywords: Parkinson's disease, Gait disorder, Levodopa, MDS-UPDRS III, machine learning

Received: 12 Nov 2024; Accepted: 23 Jul 2025.

Copyright: © 2025 Yin, Gao, Liang, Liu, Liu, Shen, Niu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Cui Wang, Central Hospital of Dalian University of Technology, Dalian, Liaoning Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.